Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by theNormon Sep 27, 2022 5:00pm
169 Views
Post# 34990533

Cardiologists like VMS+

Cardiologists like VMS+
Which now has an innovative Sensor Tracking System attached to the Ultrasound Probe that allows the patient to be repositioned during the exam without affecting the results. Simple, intuitive, fast and accurate is what people who try it are saying again and again. VPT sales associates are processing 100's of inquiries and scheduling demo's. GEHC is close to official launch of 4D which has already been demonstrated in Spain with people extremely impressed in the results. These low share prices continue to be a gift thanks to war and inflation AND the NDA preventing George from discussing anything regarding GEHC. Nov 1 NICE will publish their recommendation to National Health Service in the UK. Ultra-low risk investing here now. "The best kept secret on the Venture" until Nov 1 IMO Cheers
<< Previous
Bullboard Posts
Next >>